von Schweinitz Benjamin A, De Lorenzo Robert A, Cuenca Peter J, Anschutz Richard L, Allen Paul B
Department of Emergency Medicine, San Antonio Military Medical Center, JBSA-Fort Sam Houston, TX, 78234, USA,
Intern Emerg Med. 2015 Feb;10(1):55-61. doi: 10.1007/s11739-014-1129-9. Epub 2014 Oct 17.
Non-invasive hemoglobin measuring technology has potential for rapid, portable, and accurate way of providing identification of blood loss or anemia. Our objective is to determine if this technology is reliable in critically ill patients presenting to the Emergency Department. Prospective cross-sectional observational study was done at an urban level-one trauma center, 135 subjects were conveniently sampled, suspected of having active bleeding, sepsis, or other critically ill condition. Non-invasive measurements with Masimo (Irvine, CA, USA) Radical-7 and Rad-57 hemoglobin monitors were compared with the Beckman-Coulter LH-550 (Brea, CA, USA) clinical laboratory blood cell analyzer. The primary outcome was the relationship of the non-invasive device to the clinical laboratory results. Secondary evaluations included the effect of pulse rate, systolic BP, respiratory rate, temperature, capillary refill, skin color, nail condition, extremity movement. The Radical-7 was able to capture reading in 78% (88/113) of subjects, and the Rad-57 in 65% (71/110) of subjects. The correlation (R(2)) of the device Hb was 0.69 and 0.67 (p < 00.01) for the Radical-7 and Rad-57, respectively. The coefficient of variation for the Radical-7 was 18%, and for the Rad57 it was 13%. Univariate analysis shows none of the observed factors is associated with the difference values between the device Hb and laboratory Hb. Our results show that Radical-7 and Rad-57 devices do not report readings in 29% of patients and accuracy is significantly lower than reported by the manufacturer with over 50% of readings falling outside of ± 1 g/dL. We determined that none of the several potential factors examined are associated with the degree of device accuracy.
非侵入性血红蛋白测量技术具有以快速、便携且准确的方式识别失血或贫血情况的潜力。我们的目标是确定该技术在急诊科的危重症患者中是否可靠。在一家城市一级创伤中心进行了前瞻性横断面观察性研究,方便抽取了135名疑似有活动性出血、败血症或其他危重症的受试者。将美国加利福尼亚州尔湾市Masimo公司的Radical - 7和Rad - 57血红蛋白监测仪的非侵入性测量结果与美国加利福尼亚州布雷亚市贝克曼库尔特公司的LH - 550临床实验室血细胞分析仪的结果进行比较。主要结果是该非侵入性设备与临床实验室结果之间的关系。次要评估包括心率、收缩压、呼吸频率、体温、毛细血管再充盈、肤色、指甲状况、肢体活动的影响。Radical - 7能够获取113名受试者中78%(88/113)的读数,Rad - 57能够获取110名受试者中65%(71/110)的读数。Radical - 7和Rad - 57设备血红蛋白(Hb)测量值的相关性(R²)分别为0.69和0.67(p < 0.01)。Radical - 7的变异系数为18%,Rad - 5y的变异系数为13%。单因素分析表明,所观察到的因素均与设备Hb测量值和实验室Hb测量值之间的差值无关。我们的结果表明,Radical - 7和Rad - 57设备在29%的患者中无法获取读数,且准确性显著低于制造商报告的结果,超过50%的读数偏离±1 g/dL范围。我们确定,所检查的几个潜在因素均与设备准确性程度无关。